OSspray’s Research and Development Department is lead by Dr. Ian Thompson at OSspray’s headquarters in London, England. Working with researchers, dentists, maxillofacial surgeons, hygienists, and scientists at King’s College and Guy’s Hospital in London, OSspray develops products that meet oral health care needs of patients with innovative minimally invasive solutions. OSspray performs lab testing, clinical research and clinical trials for our products to meet the highest quality standards and regulatory compliance.

Biomaterials and their delivery systems are the foundation of OSspray’s product innovation and with the launch of our first therapeutic prophy powder, Sylc™, we are committed to further developments for restorative, orthodontic, periodontal and remineralisation applications to address minimally invasive dentistry and caries management needs. The completion of these developments in the coming years will create a portfolio of next generation dental therapeutic products. These products will provide improved outcomes for patients, hygienists, dentists and dental specialists around the world.